1. Gain insights into the appropriate laboratory studies and evaluations for psoriasis patients on systemic therapies. (Abby vanVoorhees, Not if but rather what to screen for psoriasis patients on immunosuppressive therapies)
2. Similar to diabetes and rheumatoid arthritis, moderate to severe psoriasis increases the risk for cardiovascular events. (Joel Gelfand, Cardiovascular risk in psoriasis: Implications for your clinical practice)
3. Bacteria play critical roles in psoriasis and eczema. (Herbert Allen, Frontiers in Dermatology)
4. Tonsillectomy may significantly decrease the burden of psoriasis in patients with recurrent Streptococcal infections. (James Treat, Whats new in pediatric dermatology)
5. Cutaneous lupus erythematosus significantly impacts quality of life. (Victoria Werth, Cutaneous lupus erythematosus: New developments in pathogenesis and treatment.)
6. Anti-cd20 and anti-BAFF agents may provide novel therapeutic approaches for pemphigus. (Aimee Payne, Whats new in pemphigus therapy)
7. Personal experience is powerful, but not generalizable. (Joslyn Kirby, How to read a paper: Common sense and statistics)
8. Critically read tables and figures to uncover the hidden meaning. (Joslyn Kirby, How to read a paper: Common sense and statistics)
9. Severe cases of DRESS/DISH with documented HHV6 reactivation may benefit from adjuvant Ganciclovir. (Warren Heyman, HHV6 and 7: Pathogenic in DRESS syndrome?)
10. Kappa opioids such as Butrophenol are effective treatment for severe intractable chronic itch. (Gil Yosipovitch, Clinical cases of chronic itch and their management)
11. Topical compounded drugs that target ion channels in skin nerves have anti-pruritic effect. (Gil Yosipovitch, Clinical cases of chronic itch and their management)
12. A nail unit biopsy will have the highest yield when taken from the anatomic area that is the origin of the clinical sign. (Adam Rubin, Nail unit biopsy techniques for optimal evaluation of inflammatory disorders)
13. Most dysplastic nevi even with positive pathology margins can be followed clinically. (Rosalie Elenitsas, Dermatopathology update)
14. Dermatoscopy can decrease the number of benign biopsies for every biopsy detecting melanoma. (Jason Lee, Dermatoscopy: When is it useful and when is it not)
15. Preserving scarce donor organs may demand pre-transplant wait periods for patients with a history of high-risk squamous cell carcinomas. (Christina Chung, When to transplant a patient with a history of skin cancer)
16. Hair follicle stem cells are intact in the balding scalp. (George Cotsarellis, New understanding of androgenetic alopecia)
17. Assessing efficacy of and toxicity from melanoma immunotherapies requires new approaches different from those used with traditional cytotoxic chemotherapy. (Tara Gangadhar, Advances in systemic therapy for melanoma)
18. Several factors not included in AJCC staging of melanoma convey important prognostic information. (Michael Ming, Looking beyond thickness in melanoma management)
19. Somatic mutation profiling of melanoma tissue is used to predict response to treatment. (Emily Chu, Genetic testing for melanoma: An update)
20. Complete pathologic assessment of melanoma and excision margins prior to reconstruction improves staging and management. (Christopher Miller, Practical issues in the management of melanoma)
21. Activation of innate immunity with Toll-like receptor agonists can be highly beneficial for treatment of CTCL. (Alain Rook, Activation of innate immunity to treat CTCL).
22. Careful attention to the static and dynamic 3-dimensional changes in facial aging can lead to optimal rejuvenation with fillers and neurotoxins. (Anthony V. Benedetto, A 3-D approach to facial rejuvenation)
23. Select the proper sclerosant agent and concentration to treat varicose and telangiectatic leg veins. (Todd Cartee, Leg vein disease: A dermatologists perspective on a dermatologic disease)